CAPR
Price
$6.32
Change
-$0.65 (-9.33%)
Updated
May 9, 04:59 PM (EDT)
Capitalization
314.71M
4 days until earnings call
TRML
Price
$15.06
Change
-$0.68 (-4.32%)
Updated
May 9, 04:59 PM (EDT)
Capitalization
395.35M
Ad is loading...

CAPR vs TRML

Header iconCAPR vs TRML Comparison
Open Charts CAPR vs TRMLBanner chart's image
Capricor Therapeutics
Price$6.32
Change-$0.65 (-9.33%)
Volume$103.99K
Capitalization314.71M
Tourmaline Bio
Price$15.06
Change-$0.68 (-4.32%)
Volume$5.6K
Capitalization395.35M
CAPR vs TRML Comparison Chart
Loading...
CAPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CAPR vs. TRML commentary
May 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAPR is a Hold and TRML is a Hold.

Ad is loading...
COMPARISON
Comparison
May 10, 2025
Stock price -- (CAPR: $6.97 vs. TRML: $15.74)
Brand notoriety: CAPR and TRML are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CAPR: 242% vs. TRML: 37%
Market capitalization -- CAPR: $314.71M vs. TRML: $395.35M
CAPR [@Biotechnology] is valued at $314.71M. TRML’s [@Biotechnology] market capitalization is $395.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CAPR’s FA Score shows that 0 FA rating(s) are green whileTRML’s FA Score has 1 green FA rating(s).

  • CAPR’s FA Score: 0 green, 5 red.
  • TRML’s FA Score: 1 green, 4 red.
According to our system of comparison, TRML is a better buy in the long-term than CAPR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CAPR’s TA Score shows that 4 TA indicator(s) are bullish while TRML’s TA Score has 4 bullish TA indicator(s).

  • CAPR’s TA Score: 4 bullish, 7 bearish.
  • TRML’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, TRML is a better buy in the short-term than CAPR.

Price Growth

CAPR (@Biotechnology) experienced а -45.29% price change this week, while TRML (@Biotechnology) price change was -11.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.32%. For the same industry, the average monthly price growth was +9.54%, and the average quarterly price growth was -14.72%.

Reported Earning Dates

CAPR is expected to report earnings on Aug 07, 2025.

TRML is expected to report earnings on Mar 13, 2025.

Industries' Descriptions

@Biotechnology (-6.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRML($395M) has a higher market cap than CAPR($315M). TRML YTD gains are higher at: -22.387 vs. CAPR (-49.493). CAPR has higher annual earnings (EBITDA): -34.79M vs. TRML (-89.69M). TRML has more cash in the bank: 258M vs. CAPR (85M). TRML has less debt than CAPR: TRML (244K) vs CAPR (1.65M). CAPR has higher revenues than TRML: CAPR (23.2M) vs TRML (0).
CAPRTRMLCAPR / TRML
Capitalization315M395M80%
EBITDA-34.79M-89.69M39%
Gain YTD-49.493-22.387221%
P/E RatioN/AN/A-
Revenue23.2M0-
Total Cash85M258M33%
Total Debt1.65M244K676%
FUNDAMENTALS RATINGS
CAPR: Fundamental Ratings
CAPR
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
68
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CAPRTRML
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 9 days ago
85%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
CAPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FDGTX20.69N/A
N/A
Fidelity Advisor Dividend Growth M
GSTRX8.81N/A
N/A
Goldman Sachs Strategic Growth R
NQCAX4.82N/A
N/A
Nuveen Large Cap Value Opportunities A
URNQX48.95N/A
N/A
Victory Nasdaq 100 Index R6
HFEAX53.26-0.06
-0.11%
Janus Henderson European Focus A

CAPR and

Correlation & Price change

A.I.dvisor tells us that CAPR and SNDX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CAPR and SNDX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CAPR
1D Price
Change %
CAPR100%
+1.16%
SNDX - CAPR
32%
Poorly correlated
+10.21%
MDGL - CAPR
30%
Poorly correlated
+0.25%
CCCC - CAPR
30%
Poorly correlated
+2.67%
CORT - CAPR
30%
Poorly correlated
+1.31%
TRML - CAPR
29%
Poorly correlated
+2.27%
More

TRML and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRML has been closely correlated with SPHDF. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if TRML jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRML
1D Price
Change %
TRML100%
+2.27%
SPHDF - TRML
78%
Closely correlated
N/A
IMNM - TRML
50%
Loosely correlated
+3.77%
STOK - TRML
44%
Loosely correlated
+4.50%
IPSC - TRML
43%
Loosely correlated
-0.34%
SYRE - TRML
43%
Loosely correlated
+1.18%
More